Contact
searchSearch
HMP Global
Clinical Videos

Video Supplement: Single-Device Large-Bore Thrombectomy for Combined Pulmonary Embolism and Iliac Vein Thrombosis Treatment

Giulio D'Ascoli, MD
Arianna Giannitto Giorgio, MD
Fabio Salimei, MD
Fernando Lozano Ruiz-Poveda, MD, PhD
04/09/2026

Video 1. Baseline venography showing extensive iliofemoral deep venous thrombosis involving the left common iliac vein.

Video 2. Post-thrombectomy venography demonstrating venous patency after mechanical thrombectomy with the FlowTriever system (Inari Medical).

© 2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Journal of Invasive Cardiology or HMP Global, their employees, and affiliates. 
 


Related Content

Pulmonary Embolism
New STORM-PE Data Show Computer-Assisted Vacuum Thrombectomy With Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients 
04/13/2026
“Together with the initial STORM PE results, which demonstrated faster reperfusion and improved right ventricular recovery, this 90-day data highlights significant patient centered benefits of CAVT in intermediate high risk PE,” said Robert...
“Together with the initial STORM PE results, which demonstrated faster reperfusion and improved right ventricular recovery, this 90-day data highlights significant patient centered benefits of CAVT in intermediate high risk PE,” said Robert...
“Together with the initial STORM...
04/13/2026
Cath Lab Digest
Clinical Images
Single-Device Large-Bore Thrombectomy for Combined Pulmonary Embolism and Iliac Vein Thrombosis Treatment
04/09/2026
Giulio D'Ascoli, MD; Arianna Giannitto Giorgio, MD; Fabio Salimei, MD; Fernando Lozano Ruiz-Poveda, MD, PhD
A 41-year-old man presented with dyspnea and elevated troponin levels. Computed tomography pulmonary angiography confirmed pulmonary embolism with obstruction of the left main pulmonary artery (PA) and distal thrombus in the right PA.
A 41-year-old man presented with dyspnea and elevated troponin levels. Computed tomography pulmonary angiography confirmed pulmonary embolism with obstruction of the left main pulmonary artery (PA) and distal thrombus in the right PA.
A 41-year-old man presented with...
04/09/2026
Journal of Invasive Cardiology
ACC 2026
Boston Scientific Presents Two Late-Breaking Trials at ACC 2026 Highlighting New Evidence in Stroke Prevention for AFib and Treatment of Intermediate-Risk Pulmonary Embolism
03/30/2026
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
At the American College of...
03/30/2026
Cath Lab Digest
Thrombectomy
Avantec Vascular, a NIPRO Company, Announces FDA 510(k) Clearance of Thrombectomy System
02/10/2026
Sunnyvale, California – Avantec Vascular, a NIPRO Company, has received FDA 510(k) clearance for a thrombectomy system that will enable a new type of treatment for patients with thrombus in the peripheral venous...
Sunnyvale, California – Avantec Vascular, a NIPRO Company, has received FDA 510(k) clearance for a thrombectomy system that will enable a new type of treatment for patients with thrombus in the peripheral venous...
Sunnyvale, California...
02/10/2026
Cath Lab Digest

News

Uncontrolled Hypertension
Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
05/13/2026
Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) by the end of Q3 2026    Orchestra BioMed and Medtronic plc, the Company’s strategic collaborator for the BACKBEAT Trial,...
Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) by the end of Q3 2026    Orchestra BioMed and Medtronic plc, the Company’s strategic collaborator for the BACKBEAT Trial,...
Orchestra BioMed targeting...
05/13/2026
Cath Lab Digest
Artis Interventional Systems (Siemens Healthineers)
AI + Imaging Systems
Siemens Healthineers Receives FDA Clearance for Six New Interventional Systems With Optiq AI Imaging Chain
05/12/2026
The Optiq AI imaging chain common to all six systems uses AI to analyze and optimize image data in real time. The six new systems address a wide range of clinical uses, operational needs, and financial considerations.
The Optiq AI imaging chain common to all six systems uses AI to analyze and optimize image data in real time. The six new systems address a wide range of clinical uses, operational needs, and financial considerations.
The Optiq AI imaging chain...
05/12/2026
Cath Lab Digest
Shockwave C2 Aero, a next generation coronary IVL catheter addresses unmet needs in deliverability, lesion crossing, and balloon repositioning.
Coronary IVL
Johnson & Johnson Advances the Standard of Calcium Modification With Global Launch of Shockwave™ C2 Aero Coronary IVL Catheter
05/12/2026
“Shockwave C2 Aero makes it easier to navigate tortuous coronary anatomy without relying on additional upfront ancillary devices," said Margaret McEntegart, MD, PhD.
“Shockwave C2 Aero makes it easier to navigate tortuous coronary anatomy without relying on additional upfront ancillary devices," said Margaret McEntegart, MD, PhD.
“Shockwave C2 Aero makes it...
05/12/2026
Cath Lab Digest
Heart Failure
‘Lemon-on-Sticks’ Phenotype Indicates Poor Prognosis in Heart Failure 
05/11/2026
Patients with the ‘lemon-on-sticks’ phenotype (low BMI/high WHR) showed the strongest signs of congestion, had the highest concentrations of the heart strain biomarker, N-terminal pro-B-type natriuretic peptide, and presented with a...
Patients with the ‘lemon-on-sticks’ phenotype (low BMI/high WHR) showed the strongest signs of congestion, had the highest concentrations of the heart strain biomarker, N-terminal pro-B-type natriuretic peptide, and presented with a...
Patients with the...
05/11/2026
Cath Lab Digest
Robotic Systems
Robocath Completes Enrollment in First-In-Human (FIH) Study of Next-Gen Robotic Platform in Interventional Cardiology
05/11/2026
“We have demonstrated that robotic assistance can be safely and reliably applied to the full spectrum of coronary lesion complexity, including the most challenging anatomies," said Dr. Mohammed Nejjari.
“We have demonstrated that robotic assistance can be safely and reliably applied to the full spectrum of coronary lesion complexity, including the most challenging anatomies," said Dr. Mohammed Nejjari.
“We have demonstrated that...
05/11/2026
Cath Lab Digest
IVUS+OCT
Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging
05/08/2026
- First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging  - Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion TORONTO-- Conavi Medical Corp.,...
- First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging  - Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion TORONTO-- Conavi Medical Corp.,...
- First co-registered and...
05/08/2026
Cath Lab Digest
Wearable AF Screening
Smartwatch Screening Detects More Atrial Fibrillation in High-Risk US Adults
05/08/2026
Laura Simson, MA
The randomized EQUAL trial showed that smartwatch-based atrial fibrillation (AF) screening increased detection rates more than 4-fold vs usual care in older adults with elevated stroke risk.
The randomized EQUAL trial showed that smartwatch-based atrial fibrillation (AF) screening increased detection rates more than 4-fold vs usual care in older adults with elevated stroke risk.
The randomized EQUAL trial...
05/08/2026
Journal of Invasive Cardiology
Device Longevity
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
05/05/2026
The COMMENCE trial provides prospective, 10-year data demonstrating the durability of Edwards’ RESILIA tissue and its role in lifetime management for patients with aortic stenosis.
The COMMENCE trial provides prospective, 10-year data demonstrating the durability of Edwards’ RESILIA tissue and its role in lifetime management for patients with aortic stenosis.
The COMMENCE trial provides...
05/05/2026
Cath Lab Digest
Stroke
Newly Published Study Shows Sensome Clot-Sensing Guidewire Accurately Reveals True Clot Make-Up in Fully Occluded Brain Vessels for First Time
05/05/2026
By integrating the world’s smallest electrical impedance sensor with predictive algorithms into a standard 0.014” guidewire, the Clotild clot-sensing guidewire is designed to provide physicians with real-time, in situ biological intelligence...
By integrating the world’s smallest electrical impedance sensor with predictive algorithms into a standard 0.014” guidewire, the Clotild clot-sensing guidewire is designed to provide physicians with real-time, in situ biological intelligence...
By integrating the world’s...
05/05/2026
Cath Lab Digest
Non-Obstructive HCM
Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Non-Obstructive Hypertrophic Cardiomyopathy
05/05/2026
SOUTH SAN FRANCISCO, Calif. -- Cytokinetics, Incorporated announced positive topline results from ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM), the pivotal Phase 3...
SOUTH SAN FRANCISCO, Calif. -- Cytokinetics, Incorporated announced positive topline results from ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM), the pivotal Phase 3...
SOUTH SAN FRANCISCO, Calif. --...
05/05/2026
Cath Lab Digest

Latest

SCAI CAIC logo
SCAI 2026
Left Atrial Appendage Occlusion Outside the Box: New Frontiers in Patient Selection
05/08/2026
Laura Simson, MA
In this 2026 SCAI session, Dr Saibal Kar explored how LAAO is moving beyond its traditional use in patients with nonvalvular AFib who are ineligible for anticoagulation.
In this 2026 SCAI session, Dr Saibal Kar explored how LAAO is moving beyond its traditional use in patients with nonvalvular AFib who are ineligible for anticoagulation.
In this 2026 SCAI session, Dr...
05/08/2026
Journal of Invasive Cardiology
Wearable AF Screening
Smartwatch Screening Detects More Atrial Fibrillation in High-Risk US Adults
05/08/2026
Laura Simson, MA
The randomized EQUAL trial showed that smartwatch-based atrial fibrillation (AF) screening increased detection rates more than 4-fold vs usual care in older adults with elevated stroke risk.
The randomized EQUAL trial showed that smartwatch-based atrial fibrillation (AF) screening increased detection rates more than 4-fold vs usual care in older adults with elevated stroke risk.
The randomized EQUAL trial...
05/08/2026
Journal of Invasive Cardiology
Original Contribution
Real-World Analysis of Outcomes of Patients Undergoing Coronary Intravascular Lithotripsy Versus Atherectomy for Calcified Coronary Artery Disease: Findings From the TriNetX Database
05/04/2026
Vikash Jaiswal, MD; Muhammad Hanif, MD; Yusra Mashkoor, MBBS; Aymen Ahmed, MBBS; Gregory Mishkel, MD; Jonathan Rosenberg, MD; Mark J. Ricciardi, MD; Arman Qamar, MD, MPH
This real-world study compared outcomes of coronary intravascular lithotripsy vs atherectomy using the TriNetX Global Collaborative Network.
This real-world study compared outcomes of coronary intravascular lithotripsy vs atherectomy using the TriNetX Global Collaborative Network.
This real-world study compared...
05/04/2026
Journal of Invasive Cardiology
Clinical Images
Late Endovascular Aneurysm Repair Limb Occlusion Presenting as Claudication: Lifelong Surveillance Essential
05/04/2026
Ping Hu, MD; Xin-yu Wang, MD; Ming Qi, MD; Jie Wang, MD; Xiao-Jing Ma, PhD
A 55-year-old man presented with medically controlled essential hypertension and a history of abdominal aortic aneurysm stenting 2 years prior who presented with a 3-month history of left lower extremity fatigue on exertion.
A 55-year-old man presented with medically controlled essential hypertension and a history of abdominal aortic aneurysm stenting 2 years prior who presented with a 3-month history of left lower extremity fatigue on exertion.
A 55-year-old man presented with...
05/04/2026
Journal of Invasive Cardiology
Brief Communication
Clinical Outcomes After Transcatheter Aortic Valve Replacement by Sex and Subtype of Low-Flow Aortic Stenosis
05/04/2026
Eileen Galvani, MD; Oludamilola Akinmolayemi, MD, MPH; Srivatsan Swaminathan, BS; Carlo Mannina, MD; Sahil Khera, MD, MPH; Lucy M. Safi, DO; Gilbert H.L. Tang, MD, MSc, MBA; Samin K. Sharma, MD; Annapoorna S. Kini, MD; Stamatios Lerakis, MD, PhD
The authors hypothesized that among patients with low-flow aortic stenosis (LFAS), outcomes differ based on sex and subtype of LFAS: classical, paradoxical, and high gradient.
The authors hypothesized that among patients with low-flow aortic stenosis (LFAS), outcomes differ based on sex and subtype of LFAS: classical, paradoxical, and high gradient.
The authors hypothesized that...
05/04/2026
Journal of Invasive Cardiology
SCAI CAIC logo
SCAI 2026
Pivotal Structural and Coronary Trials Driving Practice Change in 2025
04/30/2026
Laura Simson, MA
This 2026 SCAI session highlighted the most influential trial data across coronary and structural heart disease from 2025.
This 2026 SCAI session highlighted the most influential trial data across coronary and structural heart disease from 2025.
This 2026 SCAI session...
04/30/2026
Journal of Invasive Cardiology
Clinical Images
Caught in the Web: Alteplase-Assisted Rescue of an Entrapped Pericardial Pigtail
04/30/2026
Swaminathan Krishnaswamy, MBBS, MD; Shivam Goel, MBBS, MD, DM; Shashwat Joshi, MBBS; Ankur Handa, MBBS, MD, DM; Sivasubramanian Ramakrishnan, MBBS, MD, DM; Sourabh Agstam, MBBS, MD, DM
A 12-year-old boy with a case of disseminated tuberculosis who was on guideline-directed oral antitubercular therapy presented to the outpatient clinic with worsening exertional dyspnea for the past 2 months.
A 12-year-old boy with a case of disseminated tuberculosis who was on guideline-directed oral antitubercular therapy presented to the outpatient clinic with worsening exertional dyspnea for the past 2 months.
A 12-year-old boy with a case of...
04/30/2026
Journal of Invasive Cardiology
Original Contribution
Extracorporeal Versus Conventional Cardiopulmonary Resuscitation for Out-of-Hospital Cardiac Arrests
04/29/2026
Tara Seirafi; Jeremy Y. Levett, MD; Areesha Moiz, MSc; Tetiana Zolotarova, MD; Kristian B. Filion, PhD; Adelina Dobromir Angheluta; Pauline Reynier, MSc; Mark J. Eisenberg, MD, MPH
The authors sought to determine the efficacy of extracorporeal cardiopulmonary resuscitation vs conventional cardiopulmonary resuscitation among patients with out-of-hospital cardiac arrests in the pre-hospital setting.
The authors sought to determine the efficacy of extracorporeal cardiopulmonary resuscitation vs conventional cardiopulmonary resuscitation among patients with out-of-hospital cardiac arrests in the pre-hospital setting.
The authors sought to determine...
04/29/2026
Journal of Invasive Cardiology
SCAI CAIC logo
SCAI 2026
Association of Tirzepatide Use With Clinical Outcomes After Transcatheter Aortic Valve Replacement in Obese Patients: A Propensity-Matched Real-World Study
04/27/2026
Ibrahim Mortada, MD
Dr Ibrahim Mortada shares insights on his study, "Association of Tirzepatide Use with Clinical Outcomes After TAVR in Obese Patients: A Propensity-Matched Real-World Study," presented at the 2026 SCAI Scientific Sessions.
Dr Ibrahim Mortada shares insights on his study, "Association of Tirzepatide Use with Clinical Outcomes After TAVR in Obese Patients: A Propensity-Matched Real-World Study," presented at the 2026 SCAI Scientific Sessions.
Dr Ibrahim Mortada shares...
04/27/2026
Journal of Invasive Cardiology
SCAI CAIC logo
SCAI 2026
GLP-1–Based Drug Tirzepatide Reduces Heart Risk in High-Risk Patients
04/27/2026
Studies link treatment to fewer deaths and cardiovascular events after widely used cardiac procedures.
Studies link treatment to fewer deaths and cardiovascular events after widely used cardiac procedures.
Studies link treatment to fewer...
04/27/2026
Journal of Invasive Cardiology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use